Matthew Angel

CEO and President, Director, 10% owner, Tempest Therapeutics, Inc.

Bought, 12 months

$1.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Mar 24, 2026

Companies

Tempest Therapeutics, Inc.CEO and President, Director, 10% owner +$1.0M

Trades

TPST Bought 231,482 shares at $2.16 $0.5M Mar 24

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.